Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Simanek

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Wiener Medizinische Wochenschrift (1946)|April 30, 2014
[A case report of the difficulty treating an endstage oncologic ENT patient with parenteral nutrition]Ulrike Uxa-Benold, Ralph Simanek, Annette Henry, et al.
Wiener Klinische Wochenschrift|May 27, 2010
[Comorbidity oriented oncology - an overview]Ralph Simanek, Michael Wuensch, Roland Edlinger, et al.
Haematologica|March 7, 2007
Venous thromboembolism--a manifestation of the metabolic syndromeCihan Ay, Theres Tengler, Rainer Vormittag, et al.
Leukemia Research|November 23, 2013
High spontaneous granulocyte/macrophage-colony formation in patients with myelofibrosisVerena Hauer, Eva Jäger, Thamer Sliwa, et al.
Thrombosis and Haemostasis|December 8, 2007
Successful outcome in a pregnant woman with homozygous antithrombin deficiencyGuelay Alguel, Kristin Jochmans, Ralph Simanek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis StudyCihan Ay, Daniela Dunkler, Ralph Simanek, et al.
Haematologica|August 2, 2007
Risk of recurrence after a first venous thromboembolic event in young womenClarissa Laczkovics, Helga Grafenhofer, Alexandra Kaider, et al.
European Journal of Haematology|May 26, 2018
High-dose Bendamustine-EAM followed by autologous stem cell rescue results in long-term remission rates in lymphoma patients, without renal toxicityThomas Noesslinger, Michael Panny, Ralph Simanek, et al.
Neuro-Oncology|March 1, 2007
Venous thromboembolism and survival in patients with high-grade gliomaRalph Simanek, Rainer Vormittag, Marco Hassler, et al.
Wiener Klinische Wochenschrift|September 26, 2015
Probability of remaining in unsustained complete remission after steroid therapy withdrawal in patients with primary warm-antibody reactive autoimmune hemolytic anemiaJohanna Kulpa, Cathrin Skrabs, Ralph Simanek, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Wiener Medizinische Wochenschrift (1946)|April 30, 2014
[A case report of the difficulty treating an endstage oncologic ENT patient with parenteral nutrition]Ulrike Uxa-Benold, Ralph Simanek, Annette Henry, et al.
Wiener Klinische Wochenschrift|May 27, 2010
[Comorbidity oriented oncology - an overview]Ralph Simanek, Michael Wuensch, Roland Edlinger, et al.
Haematologica|March 7, 2007
Venous thromboembolism--a manifestation of the metabolic syndromeCihan Ay, Theres Tengler, Rainer Vormittag, et al.
Leukemia Research|November 23, 2013
High spontaneous granulocyte/macrophage-colony formation in patients with myelofibrosisVerena Hauer, Eva Jäger, Thamer Sliwa, et al.
Thrombosis and Haemostasis|December 8, 2007
Successful outcome in a pregnant woman with homozygous antithrombin deficiencyGuelay Alguel, Kristin Jochmans, Ralph Simanek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis StudyCihan Ay, Daniela Dunkler, Ralph Simanek, et al.
Haematologica|August 2, 2007
Risk of recurrence after a first venous thromboembolic event in young womenClarissa Laczkovics, Helga Grafenhofer, Alexandra Kaider, et al.
European Journal of Haematology|May 26, 2018
High-dose Bendamustine-EAM followed by autologous stem cell rescue results in long-term remission rates in lymphoma patients, without renal toxicityThomas Noesslinger, Michael Panny, Ralph Simanek, et al.
Neuro-Oncology|March 1, 2007
Venous thromboembolism and survival in patients with high-grade gliomaRalph Simanek, Rainer Vormittag, Marco Hassler, et al.
Wiener Klinische Wochenschrift|September 26, 2015
Probability of remaining in unsustained complete remission after steroid therapy withdrawal in patients with primary warm-antibody reactive autoimmune hemolytic anemiaJohanna Kulpa, Cathrin Skrabs, Ralph Simanek, et al.
Pageof 2